These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

651 related items for PubMed ID: 22356288

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Future of cholesteryl ester transfer protein (CETP) inhibitors: a pharmacological perspective.
    Mohammadpour AH, Akhlaghi F.
    Clin Pharmacokinet; 2013 Aug; 52(8):615-26. PubMed ID: 23658137
    [Abstract] [Full Text] [Related]

  • 3. Cholesteryl ester transfer-protein modulator and inhibitors and their potential for the treatment of cardiovascular diseases.
    Shinkai H.
    Vasc Health Risk Manag; 2012 Aug; 8():323-31. PubMed ID: 22661899
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. HDL metabolism and CETP inhibition.
    Barkowski RS, Frishman WH.
    Cardiol Rev; 2008 Aug; 16(3):154-62. PubMed ID: 18414186
    [Abstract] [Full Text] [Related]

  • 8. Cholesteryl ester transfer protein inhibitors: from high-density lipoprotein cholesterol to low-density lipoprotein cholesterol lowering agents?
    Nurmohamed NS, Ditmarsch M, Kastelein JJP.
    Cardiovasc Res; 2022 Nov 10; 118(14):2919-2931. PubMed ID: 34849601
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. No cardiovascular benefit with evacetrapib - is this the end of the road for the 'cetrapibs'?
    Doggrell SA.
    Expert Opin Pharmacother; 2017 Oct 10; 18(14):1439-1442. PubMed ID: 28799819
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cholesteryl ester transfer protein inhibition to reduce cardiovascular risk: Where are we now?
    Barter P, Rye KA.
    Trends Pharmacol Sci; 2011 Dec 10; 32(12):694-9. PubMed ID: 22088767
    [Abstract] [Full Text] [Related]

  • 13. Structure-based mechanism and inhibition of cholesteryl ester transfer protein.
    Xue H, Zhang M, Liu J, Wang J, Ren G.
    Curr Atheroscler Rep; 2023 Apr 10; 25(4):155-166. PubMed ID: 36881278
    [Abstract] [Full Text] [Related]

  • 14. New horizons for cholesterol ester transfer protein inhibitors.
    Schwartz GG.
    Curr Atheroscler Rep; 2012 Feb 10; 14(1):41-8. PubMed ID: 22083134
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Treatment of dyslipidemia - is here still place for CETP-inhibitors?].
    Murín J, Pernický M, Kiňová S.
    Vnitr Lek; 2016 Feb 10; 62(10):789-794. PubMed ID: 27900865
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Current status of CETP inhibitors in the treatment of hyperlipidemia: an update.
    Ghosh RK, Ghosh SM.
    Curr Clin Pharmacol; 2012 May 10; 7(2):102-10. PubMed ID: 22432840
    [Abstract] [Full Text] [Related]

  • 19. Different effects of compounds decreasing cholesteryl ester transfer protein activity on lipoprotein metabolism.
    Niesor EJ.
    Curr Opin Lipidol; 2011 Aug 10; 22(4):288-95. PubMed ID: 21587074
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.